Form 4: GA Disposes 13.46M Alignment Healthcare Shares, Retains 30.84M
Rhea-AI Filing Summary
General Atlantic reported an open-market sale of 13,460,000 shares of Alignment Healthcare (ALHC) common stock settled on 09/12/2025 at a net price of $16.01 per share. After the transaction, General Atlantic (GA ALN) held 30,533,323 shares directly and, when combined with certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group is shown as beneficially owning 30,842,175 shares in the filing. The Form 4 identifies multiple related General Atlantic entities and states they may be deemed a group while disclaiming broader beneficial ownership. The filing is signed by Michael Gosk on 09/16/2025 and lists the reporting persons as directors-by-deputization for Section 16 purposes.
Positive
- Substantial retained stake: Reporting persons continue to beneficially own 30,842,175 shares following the sale, preserving meaningful exposure and potential voting influence.
- Transparent disclosure: The filing clearly identifies the sale amount, net price ($16.01), settlement date (09/12/2025) and affiliated entities, meeting Section 16 reporting requirements.
Negative
- Large open‑market sale: Disposition of 13,460,000 shares is sizable and could exert downward pressure on the stock if accompanied by additional selling.
- Complex ownership/group disclosure: Multiple related entities may be deemed a group, which can complicate assessment of who ultimately controls voting and investment decisions.
Insights
TL;DR: Large open-market sale by General Atlantic, but firm retains substantial stake—market impact likely limited absent other disclosures.
The reported disposition of 13.46 million ALHC shares at $16.01 is a material transaction by volume and will reduce General Atlantic's direct holdings while leaving a sizeable remaining position of 30.53 million shares (30.84 million when including certain RSUs and shares held for GASC). This filing is a routine Section 16 disclosure of an open-market sale; it does not include any forward-looking statements, additional sales, or change in board control. Investors should note the selling price and the continued significant stake held by GA entities, as both are relevant to potential voting influence and future liquidity events.
TL;DR: Multiple affiliated entities filed jointly and disclaim broader ownership; governance control appears centralized across GA vehicles.
The Form 4 details a complex ownership structure involving GA ALN and several affiliated partnerships, funds, and management entities. The filing explicitly describes how GA GenPar, GA LP, GA SPV, GAPCO Management and the Partnership Committee relate, and notes the possibility that these reporting persons could be deemed a "group." Each reporting person disclaims ownership beyond their direct holdings. The classification of reporting persons as directors-by-deputization for Section 16 purposes is procedural and is disclosed here consistently with group reporting practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share | 13,460,000 | $16.01 | $215.49M |
Footnotes (1)
- The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 13,460,000 shares of Common Stock settled on September 12, 2025 at a net price per share of $16.01. Reflects (i) 30,533,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3) (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.